BRCA1 clinical trials
Showing 51–68 of 68 active trials naming this biomarker in their eligibility criteria. Describe your situation to see which ones look like a fit.
- Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations
- Pancreas Registry and High Risk Registry
- Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
- Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
- Hormone Replacement Therapy After Risk Reducing Salpingo-oophorectomy
- Lorigerlimab (MGD019) in Patients With Pancreatic Adenocarcinoma and Homologous Recombination Deficiency
- [18F]Fluorthanatrace - Positron Emission Tomography (FTT-PET) and ctDNA to Predict Response to PARP Inhibitor Therapy in Metastatic Prostate Cancer (mPC)
- Environmental Exposure Assessment in High-Risk and Early-Onset Breast Cancer Care
- IGNITE-TX Phase III: (Identifying Individuals for Genetic Testing & Treatment) Intervention
- ACT-GEN (Adherence And Care Tracking In GENetic Cancer Syndromes)
- A Web-Based Program (Kindred) to Improve the Understanding of Genetic Cancer Risk and Cancer Genetic Testing in African American Families
- Prospective Familial Registry for Pancreas Research
- Patient Centered Clinical Decision Support for Hereditary Cancer Syndromes
- Genetic Education in BRCA Families
- High-Risk Metachronous Oligometastatic Prostate Cancer Trial
- Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With Select HRR Gene Alterations
- Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations
- FaCT Trial (Facilitated Cascade Testing Trial)
Guides for people searching for a trial
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.